enVVeno Medical
NVNO
15 hedge funds and large institutions have $8.74M invested in enVVeno Medical in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 6 closing their positions.
461% more call options, than puts
Call options by funds: $2.81M | Put options by funds: $500K
42% more capital invested
Capital invested by funds: $6.16M → $8.74M (+$2.57M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
7% more funds holding
Funds holding: 14 → 15 (+1)
0.05% less ownership
Funds ownership: 0.3% → 0.25% (-0.05%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
+$1.94M |
| 2 |
Morgan Stanley
New York
|
+$1.27M |
| 3 |
LSA
L & S Advisors
Los Angeles,
California
|
+$222K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$117K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$90.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.38M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$569K |
| 3 |
KC
Kepos Capital
New York
|
-$491K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$437K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$56.2K |
NVNO Hedge Fund Activity: Q3 2021 in Review
15 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2021, worth a combined $8.74M — up 42% from $6.16M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NVNO positions and 6 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was ACT Capital Management, opening a new position worth an estimated $1.94M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.38M sold.
- 15 institutional investors held enVVeno Medical (NVNO) as of Q3 2021, up from 14 in Q2 2021.
- Funds reported $8.74M of enVVeno Medical stock for Q3 2021, up 42% quarter-over-quarter.
- 7 funds opened new enVVeno Medical positions in Q3 2021 and 6 closed out, a net change of +1 holder.
- The largest enVVeno Medical buyer in Q3 2021 was ACT Capital Management, an estimated $1.94M added.
- The largest enVVeno Medical seller in Q3 2021 was AIGH Capital Management, an estimated $2.38M sold.
Based on aggregated 13F filings for Q3 2021.